Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)

Clinical trial NCT04585412 · COMPLETED

Trial details

NCT number: NCT04585412
Sponsor: Yung Shin Pharm. Ind. Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting, Prophylaxis

Start date: 2020-08-17
Primary completion: 2020-10-24
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.